Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening illness caused by the parasite Trypanosoma cruzi. Despite being first discovered over a century ago, Chagas disease remains a neglected tropical disease, affecting millions of people mainly in Latin America, with growing cases worldwide due to migration.

In this blog, we will dive into what Chagas disease is, how it spreads, its symptoms, diagnosis, treatment, and why global awareness is so important.

Chagas disease is a parasitic infection transmitted primarily by triatomine bugs, often called “kissing bugs” because they tend to bite around the lips or face during the night. The disease progresses in two phases: acute and chronic. While the initial infection might cause mild or no symptoms, the chronic phase can lead to serious heart and digestive system complications decades later.

How is Chagas Disease Transmitted?

The main mode of transmission is through the feces of infected triatomine bugs. After biting a person, the bug defecates near the bite wound, and the parasites enter the body when a person inadvertently rubs the contaminated feces into the bite site, eyes, mouth, or an open wound.

Other less common routes of transmission include:

• Mother-to-child during pregnancy (congenital transmission)
• Blood transfusions or organ transplants from an infected donor
• Consumption of contaminated food or beverages
• Laboratory accidents involving exposure to the parasite

Although primarily a rural disease linked to poor housing conditions, Chagas disease has increasingly appeared in urban areas and non-endemic countries due to travel and migration.

Symptoms of Chagas Disease

Acute Phase

The acute phase occurs shortly after infection and can last for a few weeks or months. Symptoms are often mild or absent, but when they occur, they may include:

• Fever
• Fatigue
• Swollen glands
• Body aches
• Rash
• Swelling around the site of infection (called a chagoma)
• Swelling of the eyelids (Romaña’s sign) if the parasite enters through the eye

Because the symptoms are non-specific, the acute phase often goes unrecognized.

Chronic Phase

If untreated, the infection can persist silently for decades. About 20-30% of infected individuals eventually develop serious health problems, including:

• Heart disease: Enlarged heart (cardiomyopathy), heart failure, arrhythmias, and sudden cardiac death
• Digestive problems: Enlarged esophagus (megaesophagus) or colon (megacolon) leading to swallowing difficulties and severe constipation
• Neurological complications: Less commonly, the nervous system may also be affected

Diagnosis

Diagnosing Chagas disease can be challenging, especially during the chronic phase when parasite levels in the blood are low.

• Acute Phase: Blood tests can directly detect the parasite under a microscope or through specialized molecular techniques like PCR (polymerase chain reaction).
• Chronic Phase: Diagnosis typically relies on serological tests that detect antibodies against T. cruzi. Two different types of tests are usually required to confirm the diagnosis.

Early detection is crucial to prevent disease progression and complications.

Treatment Options

Treatment is most effective during the acute phase but can still offer benefits in chronic infection, especially before significant organ damage occurs.

• Medications: Two antiparasitic drugs, benznidazole and nifurtimox, are used to treat Chagas disease. Treatment courses can last from 60 to 90 days and may cause side effects, which need to be managed under medical supervision.
• Symptom Management: In the chronic phase, managing complications such as heart disease or digestive problems often involves specialized care, including medications, surgeries, or the implantation of medical devices like pacemakers.

Treatment guidelines differ slightly depending on the patient’s age, phase of infection, and severity of symptoms.

Prevention Strategies

There is no vaccine for Chagas disease yet, making prevention strategies vital:

• Vector Control: Improving housing conditions, using insecticides, and screening homes in endemic areas help reduce contact with triatomine bugs.
• Blood and Organ Screening: Routine screening of blood and organ donors helps prevent transmission in healthcare settings.
• Education: Raising awareness about Chagas disease, its transmission, and prevention is crucial, especially in rural communities.

Global Impact and Challenges

Chagas disease affects approximately 6 to 7 million people worldwide, primarily in Latin America, but cases have been identified in the United States, Europe, Japan, and Australia due to migration. However, because it disproportionately affects impoverished communities, it remains largely underfunded and overlooked in global health discussions.

Increased investment in research, improved access to diagnostics and treatment, and integrated public health efforts are essential to control and eventually eliminate this disease.

Conclusion

Chagas disease is a silent but significant health threat, often hidden until it causes severe and irreversible damage. By improving awareness, strengthening healthcare infrastructure, and focusing on early detection and treatment, we can change the future for millions affected by this neglected disease. The fight against Chagas disease requires a global commitment to equity, education, and innovation.

The list of some Chagas Disease medicine:
Lampit